Alcon Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
13.5%projected annual EPS growth
Analyst Coverage
15analysts covering
FY Revenue (est.)
$11.1Bnext fiscal year
FY EPS (est.)
$3.50next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 11 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Constant-Currency Net Sales Growth Quarterly6.0%Target: 5% to 7% for FY 2026
Core Diluted EPS Growth Quarterly9.0%Target: 9% to 12% for FY 2026
Annual Free Cash Flow Annually1.7BTarget: Continued strong cash generation to support capital returns
Watch Items
- Tariff-related cost pressuresTrigger: Net tariff impact exceeding $125M to $175M range in FY 2026Action: Accelerate operational efficiency programs and adjust pricing strategies where possible
- Unity platform commercial rolloutTrigger: Slowing equipment upgrade cycles or lower-than-expected consumables pull-throughAction: Reallocate sales and clinical training resources to high-priority surgical centers
- Competitive pressure in premium PC-IOLsTrigger: Loss of market share in the U.S. PC-IOL category to J&J Vision or other rivalsAction: Increase marketing support and clinical education for PanOptix Pro and Clareon platforms
Research as of 2 Sep 2026